Skip to main content
. 2023 Jun 21;10:1208006. doi: 10.3389/fmed.2023.1208006

Table 1.

Listing of socio-demographic and clinical data of n = 291 SLE patients [BC Broad Consent, Q1 first quartile, Q3 third quartile, SLEDAI Systemic Lupus Erythematosus Disease Activity Index, HAQ Health Assessment Questionnaire (Score calculated from the Funktionsfragebogen Hannover (FFbH))].

All Consented to all BC items Lack of consent on individual BC items
N 291 286 5
Age, median [Q1, Q3] 44.0 [33.8, 53.0] 44.0 [33.0, 53.0] 40.5 [39.3, 48.5]
Sex = female, n (%) 251 (86.3) 246 (86.0) 5 (100.0)
Education, n (%)
 University entrance diploma 136 (47.4) 132 (46.8) 4 (80.0)
 Another school diploma 143 (49.1) 143 (49.6) 0 (0.0)
 No school diploma 8 (2.8) 7 (2.5) 1 (20.0)
Disease duration in years, median [Q1, Q3] 15.0 [8.0, 21.0] 15.0 [8.0, 21.0] 16.0 [7.0, 22.8]
Duration of care in our center in years, median [Q1, Q3] 10.5 [5.4, 15.5] 10.5 [5.3, 15.4] 15.1 [11.8, 15.7]
Co-consent to other studies performed at our center, n (%) 249 (85.6) 245 (85.7) 4 (80)
Ever Co-consent to other studies performed at our center, n (%) 278 (93.8) 273 (95.5) 5 (100)
SLEDAI score, median [Q1, Q3] 2.0 [0.0, 5.0] 2.0 [0.0, 5.0] 4.0 [3.0, 6.0]
FFbH score, median [Q1, Q3] 94.4 [77.8, 100.0] 94.4 [77.8, 100.0] 91.7 [43.1, 98.6]
HAQ score, median [Q1, Q3] 0.52 [0.36, 0.98] 0.52 [0.36, 0.98] 0.44 [0.36, 0.63]